Diagnamed Holdings (FRA:D75) Market Cap: €4.08 Mil (As of Jun. 29, 2026)


What is Diagnamed Holdings Market Cap?

Diagnamed Holdings FRA:D75 Market Cap is €4.08 Mil as of Jun. 29, 2026. The stock has 1 warning sign investors should review. Among 694 Healthcare Providers & Services companies, Diagnamed Holdings ranks worse than 90.06% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Diagnamed Holdings's share price for the quarter that ended in Mar. 2026 was €0.049. Diagnamed Holdings's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 120.06 Mil. Therefore, Diagnamed Holdings's market cap for the quarter that ended in Mar. 2026 was €5.88 Mil.

Diagnamed Holdings's quarterly market cap increased from Sep. 2025 (€0.00 Mil) to Dec. 2025 (€3.41 Mil) and increased from Dec. 2025 (€3.41 Mil) to Mar. 2026 (€5.88 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Diagnamed Holdings's Enterprise Value for Today is €3.84 Mil.


Diagnamed Holdings  (FRA:D75) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Diagnamed Holdings Market Cap Related Terms


Diagnamed Holdings Market Cap Historical Data

* Premium members only.

The historical data trend for Diagnamed Holdings's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diagnamed Holdings Market Cap Chart

Diagnamed Holdings Annual Data
Trend Sep21 Sep22 Sep23 Sep24 Sep25
Market Cap
0.00 0.00 0.00 0.00 0.00

Diagnamed Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 3.41 5.88

FRA:D75 vs VEEV, BTSG, TEM: Market Cap Comparison

For the Health Information Services subindustry, Diagnamed Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diagnamed Holdings Market Cap vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Diagnamed Holdings's Market Cap distribution charts can be found below:

* The bar in red indicates where Diagnamed Holdings's Market Cap falls into.



Diagnamed Holdings Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Diagnamed Holdings's Market Cap for the fiscal year that ended in Sep. 2025 is calculated as

Market Cap (A: Sep. 2025 )=Share Price (A: Sep. 2025 )*Shares Outstanding (EOP) (A: Sep. 2025 )
=€0*109.159
=€0.00

Diagnamed Holdings's Market Cap for the quarter that ended in Mar. 2026 is calculated as

Market Cap (Q: Mar. 2026 )=Share Price (Q: Mar. 2026 )*Shares Outstanding (EOP) (Q: Mar. 2026 )
=€0.049*120.059
=€5.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of €4.08 Mil mean?
Diagnamed Holdings (FRA:D75) has a Market Cap of €4.08 Mil as of Jun. 29, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Diagnamed Holdings and its competitors. According to the industry distribution chart, Diagnamed Holdings ranks #625 out of 694 companies in the Healthcare Providers & Services industry, placing it in the top 90.1%.
Is Diagnamed Holdings' Market Cap too high?
Diagnamed Holdings' current Market Cap is €4.08 Mil. Based on the distribution chart, Diagnamed Holdings ranks #625 out of 694 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Diagnamed Holdings' Market Cap compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Diagnamed Holdings ranks #625 out of 694 companies for Market Cap. This places Diagnamed Holdings in the lower half of its industry. The industry median Market Cap is 93.08. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 93.08, based on 694 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Diagnamed Holdings and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 93.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Diagnamed Holdings's current Market Cap is €4.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnamed Holdings stock overvalued right now?
Diagnamed Holdings (FRA:D75) has a current Market Cap of €4.08 Mil. The current Market Cap is €4.08 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Diagnamed Holdings (FRA:D75), the current Market Cap is €4.08 Mil as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Diagnamed Holdings Business Description

Other Exchanges DGNMF:USADMED:Canada
Address 82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
Diagnamed Holdings Corp is engaged in developing a platform of software-based prescription digital therapeutic products (PDT Products) with the potential to improve early detection of neurological disorders, overall patient health and lower healthcare costs. Its products include, CERVAI which is a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It is also investigating other technological applications such as BrainAge and BrainTremor.